SOURCE: Smith & Nephew PLC

August 14, 2007 06:02 ET

Smith & Nephew PLC announces Smith & Nephew Release

London, UK--(Marketwire - August 14, 2007) -


FOR IMMEDIATE RELEASE

Contact:         Sidonie Myers

                 Head of Communication

                 Smith & Nephew Advanced Wound Management

                 +44 (0)1482 673246

                 sidonie.myers@smith-nephew.com



Smith & Nephew announces relocation of Florida based manufacturing

Hull, ENGLAND and Largo, FL, 14 August, 2007 - Smith & Nephew's (LSE: SN; NYSE:
SNN) Advanced Wound Management Division announces that, following a full review
of the cost effectiveness of its manufacturing facilities, it will be relocating
or outsourcing the manufacturing currently based in Largo Florida.  This
relocation project will take place over the next 18 to 24 months and it is
expected that the manufacturing in Largo will cease during 2009.



Smith & Nephew strategy for the Advanced Wound Management business has three key
components; an increased focus on fast growing segments of the woundcare market,
increasing sales efforts in the US and reducing costs to increase the
competitiveness of the business.



Smith & Nephew is purchasing land to provide manufacturing capacity in China and
plans for construction of a facility are underway.  ALLEVYN* Adhesive dressings,
part of Smith & Nephew's leading exudate management product range, will be
produced in China.  The production of ALLEVYN products in Hull will continue.
Other Smith & Nephew products currently manufactured in Largo will be
outsourced.



About Us



Smith & Nephew Advanced Wound Management, with headquarters in the United
Kingdom, employs more than 3,100 people around the world.  The organisation has
manufacturing centres in the United Kingdom and Largo, FL.



Smith & Nephew is a global medical technology business, specialising in
Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy
and Advanced Wound Management products.  Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading global
orthopaedics companies.



Smith & Nephew is dedicated to helping improve people's lives.  The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust.  The Company has 9,600 employees
and operates in 31 countries around the world.  Annual sales in 2006 were nearly
$2.8 billion.



Forward-Looking Statements



This press release contains certain "forward-looking statements" within the
meaning of the US Private Securities Litigation Reform Act of 1995.  In
particular, statements regarding expected revenue growth and trading margins
discussed under "Outlook" are forward-looking statements as are discussions of
our product pipeline.  These statements, as well as the phrases "aim", "plan",
"intend", "anticipate", "well-placed", "believe", "estimate", "expect",
"target", "consider" and similar expressions, are generally intended to identify
forward-looking statements.  Such forward-looking statements involve known and
unknown risks, uncertainties and other important factors (including, but not
limited to, the outcome of litigation, claims and regulatory approvals) that
could cause the actual results, performance or achievements of Smith & Nephew,
or industry results, to differ materially from any future results, performance
or achievements expressed or implied by such forward-looking statements.  Please
refer to the documents that Smith & Nephew has filed with the U.S. Securities
and Exchange Commission under the U.S. Securities Exchange Act of 1934, as
amended, including Smith & Nephew's most recent annual report on Form 20F, for a
discussion of certain of these factors.



All forward-looking statements in this press release are based on information
available to Smith & Nephew as of the date hereof.  All written or oral
forward-looking statements attributable to Smith & Nephew or any person acting
on behalf of Smith & Nephew are expressly qualified in their entirety by the
foregoing.  Smith & Nephew does not undertake any obligation to update or revise
any forward-looking statement contained herein to reflect any change in Smith &
Nephew's expectation with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.



* Trademark of Smith & Nephew.  Certain marks registered US Patent and Trademark
Office.



                                      ###


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END